Valuations remain ‘very much on paper’ as a result of limited liquidity in the market, AXA IM’s global head of alts says at PEI Group’s NEXUS 2024 summit.
The sale of DPI-backed Kelix Bio to Mubadala Investment Company was announced in March.
'It’s still possible to do deals, even big deals,' says William Kovacic, a former FTC chair. 'You have to be willing to fight cases. You have to be willing to carry the costs and go through the time it takes.'
MSCP expects to share best practices among RI and existing portfolio companies Alliance Technical Group and Apex.
Warburg Pincus’ massive expansion of Summit Health and subsequent exit earns it our overall deal of the year award as well as being the large-market winner.
Vestar’s investment in a family company founded over a century ago paid off despite difficulties of the covid era
Warburg leads the charge for best deals in our annual awards.
Ares made it rain during an IPO drought when it brought Savers Value Village to market.
BlackRock had a nose for the power of luxury, even during covid.
Kaiser deftly closed its portfolio sale last year despite market turbulence, price fluctuations and the banking crisis